IL6 and neoplasm: Neutralization of macrophage-derived IL-6 or inhibition of PGK1 T243 phosphorylation or PDPK1 in tumor cells markedly abrogates macrophage-promoted glycolysis, proliferation, and tumorigenesis (Zhang Y. et al., 2018).